The nerve growth factor/tumor necrosis factor receptor family

Journal of Leukocyte Biology

Volumn 60, Issue 1, 1996, Pages 1-7

  Lotz, Martin ^a,b   Setareh, Morey ^a   Von Kempis, Johannes ^a   Schwarz, Herbert ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell proliferation; Differentiation; Host defense

Indexed keywords

LIGAND; MEMBRANE PROTEIN; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL DEATH; CELL DIFFERENTIATION; CELL MEMBRANE; CELL PROLIFERATION; CROSS LINKING; ETIOLOGY; HOST RESISTANCE; HUMAN; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029951011     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.1.1     Document Type: Review

References (91)

1. Mallett, S., Barclay, A. N. (1991) A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol Today 12, 220-223.
2. Smith, C. A., Farrah, T., Goodwin, R. G. (1994) The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959-962.
3. Johnson, D., Lanahan, A., Buck, C. R., Sehgal, A., Morgan, C., Mercer, E., Bothwell, M., Chao, M. (1986) Expression and structure of the human NGF receptor. Cell 47, 545-554.
4. Loetscher, H., Pan, Y. C., Lahm, H. W., Gentz, R., Brockhaus, M., Tabuchi, H., Lesslauer, W. (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61, 351-359.
5. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D., Goodwin, R. G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023.
6. Kohno, T., Brewer, M. T., Baker, S. L., Schwartz, P. E., King, M. W., Hale, K. K., Squires, C. H., Thompson, R. C., Vannice, J. L. (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. USA 87, 8331-8335.
7. Baens, M., Chaffanet, M., Cassiman, J. J., van den Berghe, H., Marynen, P. (1993) Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16, 214-218.
8. Crowe, P. D., VanArsdale, T. L., Walter, B. N., Ware, C. F., Hession, C., Ehrenfels, B., Browning, J. L., Din, W. S., Coodwin, R. G., Smith, C. A. (1994) A lymphotoxin-beta-specific receptor. Science 264, 707-710.
9. Stamenkovic, I., Clark, E. A., Seed, B. (1989) A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8, 1403-1410.
10. Durkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B., Stein, H. (1992) Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421-427.
11. Camerini, D., Walz, G., Loenen, W. A., Borst, J., Seed, B. (1991) The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol. 147, 3165-3169.
12. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
13. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem. 267, 10709-10715.
14. Mallett, S., Fossum, S., Barclay, A. N. (1990) Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes - a molecule related to nerve growth factor receptor. EMBO. J. 9, 1063-1068.
15. Kwon, B. S., Weissman, S. M. (1989) cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA 86, 1963-1967.
16. Schwarz, H., Tuckwell, J., Lotz, M. (1993) A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene 134, 295-298.
17. Smith, C. A., Davis, T., Wignall, J. M., Din, W. S., Farrah, T., Upton, C., McFadden, G., Goodwin, R. G. (1991) T2 open reading frame from the Shope fibroma virus encolles a soluble form of the TNF receptor. Biochem. Biophys. Res. Commun. 176, 335-342.
18. Browning, J. L., Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E. P., Hession, C., O'Brine-Greco, B., Foley, S. F., Ware, C. F. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell 72, 847-856.
19. Armitage, R. J., Fanslow, W. C., Strockbine, L., Sato, T. A., Clifford, K. N., Macduff, B. M., Anderson, D. M., Gimpel, S. D., Davis-Smith, T., Maliszewski, C. R. (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357, 80-82.
20. Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., VandenBos, T., Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K., et al. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73, 447-456.
21. Suda, T., Takahashi, T., Golstein, P., Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
22. Goodwin, R. G., Din, W. S., Davis-Smith, T., Anderson, D. M., Gimpel, S. D., Sato, T. A., Maliszewski, C. R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., et al. (1993) Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor. Eur. J. Immunol. 23, 2631-2641.
23. + T cells with homology to tumor necrosis factor. J. Exp. Med. 180, 757-762.
24. Banner, D. W., D'Arcy, A., Janes, W., Gentz, R., Schoenfeld, H. J., Broger, C., Loetscher, H., Lesslauer, W. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell 73, 431-445.
25. Naismith, J. H., Devine, T. Q., Brandhuber, B. J., Sprang, S. R. (1995) Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem. 270, 13303-13307.
26. Barker, P. A., Miller, F. D., Large, T. H., Murphy, R. A. (1991) Generation of the truncated form of the nerve growth factor receptor by rat Schwann cells. Evidence for post-translational processing. J. Biol. Chem. 266, 19113-19119.
27. Nophar, Y., Kemper, O., Brakebusch, C., Englemann, H., Zwang, R., Aderka, D., Holtmann, H., Wallach, D. (1990) Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9, 3269-3278.
28. Seckinger, P., Zhang, J. H., Hauptmann, B., Dayer, J. M. (1990) Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor. Proc. Natl. Acad. Sci. USA 87, 5188-5192.
29. Cheng, J., Zhou, T., Liu, C., Shapiro, J. P., Brauer, M. J., Kiefer, M. C., Barr, P. J., Mountz, J. D. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263, 1759-1762.
30. Hintzen, R. Q., de Jong, R., Hack, C. E., Chamuleau, M., de Vries, E. F., ten Berge, I. J., Borst, J., Van Lier, R. A. (1991) A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J. Immunol. 147, 29-35.
31. Josimovic-Alasevic, O., Durkop, H., Schwarting, R., Backe, E., Stein, H., Diamantstein, T. (1989) Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur. J. Immunol. 19, 157-162.
32. Fanslow, W. C., Anderson, D. M., Grabstein, K. H., Clark, E. A., Cosman, D., Armitage, R. J. (1992) Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149, 655-660.
33. Setareh, M., Schwarz, H., Lotz, M. (1995) A mRNA variant encoding a soluble form of 4-1BB, a member of the murine NGF/TNF receptor family. Gene 164, 311-315.
34. Tracey, K. J., Cerami, A. (1994) Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503.
35. Eck, M. J., Sprang, S. R. (1989) The structure of tumor necrosis factor-alpha at 2.6 A resolution. Implications for receptor binding. J. Biol. Chem. 264, 17595-17605.
36. Jones, E. Y., Smart, D. I., Walker, N. P. (1989) Structure of tumour necrosis factor. Nature 338, 225-228.
37. Eck, M. J., Ultsch, M., Rinderknecht, E., de Vos, A. M., Sprang, S. R. (1992) The structure of human lymphotoxin (tumor necrosis factor-beta) at 1.9-A resolution. J. Biol. Chem. 267, 2119-2122.
38. Kolesnick, R., Golde, D. W. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77, 325-328.
39. Rothe, M., Wong, S. C., Henzel, W. J., Goeddel, D. V. (1994) A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681-692.
40. Hu, H. M., O'Rourke, K., Boguski, M. S., Dixit, V. M. (1994) A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069-30072.
41. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., Kieff, E. (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
42. Rothe, M., Sarma, V., Dixit, V. M., Coeddel, D. V. (1995) TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science 269, 1424-1427.
43. Sarma, V., Lin, Z., Clark, L., Rust, B. M., Tewari, M., Noelle, R. J., Dixit, V. M. (1995) Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270, 12343-12346.
44. Hsu, H., Xiong, J., Goeddel, D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81, 495-504.
45. Sato, T., Irie, S., Kitada, S., Reed, J. C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-415.
46. + T lymphocytes. J. Immunol. 152, 1523-1531.
47. Stuber, E., Neurath, M., Calderhead, D., Fell, H. P., Strober, W. (1995) Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2, 507-521.
48. Schwarz, H., Blanco, F., von Kempis, J., Valbracht, J., Lotz, M. (1996) ILA, a member of the human NGF/TNF receptor family regulates T lymphocyte proliferation and survival. Blood, in press.
49. Beutler, B., Cerami, A. (1989) The biology of cachectin/TNF - a primary mediator of the host response. Annu. Rev. Immunol. 7, 625-655.
50. Alderson, M. R. (1994) Regulation of immune responses by the ligands for CD27, CD30, and 4-1BB. Circ. Shock 44, 73-76.
51. Lynch, D. H. (1994) Biology of Fas. Circ. Shock 44, 63-66.
52. Hintzen, R. Q., de Jong, R., Lens, S. M., Van Lier, R. A. (1994) CD27: marker and mediator of T-cell activation? Immunol. Today 15, 307-311.
53. Falini, B., Pileri, S., Pizzolo, G., Durkop, H., Flenghi, L., Stirpe, F., Martelli, M. F., Stein, H. (1995) CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85, 1-14.
54. McGeehan, G. M., Becherer, J. D., Bast, R. C., Jr., Boyer, C. M., Champion, B., Connolly, K. M., Conway, J. G., Furdon, P., Karp, S., Kidao, S., et al. (1994) Regulation of tumour necrosis factor-alpha processing by a metallo-proteinase inhibitor. Nature 370, 558-561.
55. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., Bluethmann, H. (1993) Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
56. Pfeffer, K., Matsuyama, T., Kundig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Kronke, M., Mak, T. W. (1993) Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
57. Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C., Schreiber, R. D., Goeddel, D. V., Moore, M. W. (1994) Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
58. Mackay, F., Rothe, J., Bluethmann, H., Loetscher, H., Lesslauer, W. (1994) Differential responses of fibroblasts from wild-type and TNF-R55-deficient mice to mouse and human TNF-alpha activation. J. Immunol. 153, 5274-5284.
59. De Togni, P., Goellner, J., Ruddle, N. H., Streeter, P. R., Fick, A., Mariathasan, S., Smith, S. C., Carlson, R., Shornick, L. P., Strauss-Schoenberger, J., et al. (1994). Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707.
60. Suda, T., Nagata, S. (1994) Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873-879.
61. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
62. Loenen, W. A., de Vries, E., Gravestein, L. A., Hintzen, R. Q., Van Lier, R. A., Borst, J. (1992) The CD27 membrane receptor, a lymphocyte-specific member of the nerve growth factor receptor family, gives rise to a soluble form by protein processing that does not involve receptor endocytosis. Eur. J. Immunol. 22, 447-455.
63. Sunder-Plassmann, R., Pickl, W. F., Majdic, O., Knapp, W., Holter, W. (1995) Crosslinking of CD27 in the presence of CD28 costimulation results in T cell proliferation and cytokine production. Cell. Immunol. 164, 20-27.
64. Agematsu, K., Kobata, T., Sugita, K., Freeman, G. J., Beckmann, M. P., Schlossman, S. F., Morimoto, C. (1994) Role of CD27 in T cell immune response. Analysis by recombinant soluble CD27. J. Immunol. 153, 1421-1429.
65. - T cell subset contains specialized primed T cells. J. Immunol. 154, 17-25.
66. Hintzen, R. Q., de Jong, R., Lens, S. M., Brouwer, M., Baars, P., Van Lier, R. A. (1993) Regulation of CD27 expression on subsets of mature T-lymphocytes. J. Immunol. 151, 2426-2435.
67. + B lymphocyte subset. J. Immunol. 148, 3700-3705.
68. Goodwin, R. G., Alderson, M. R., Smith, C. A., Armitage, R. J., VandenBos, T. Jerzy, R., Tough, T. W., Schoenborn, M. A., Davis-Smith, T., Hennen, K., et al. (1993) Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 73, 447-456.
69. Hintzen, R. Q., Lens, S. M., Lammers, K., Kuiper, H., Beckmann, M. P., Van Lier, R. A. (1995) Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154, 2612-2623.
70. Hintzen, R. Q., Lens, S. M., Koopman, G., Pals, S. T., Spits, H., Van Lier, R. A. (1994) CD70 represents the human ligand for CD27. Int. Immunol. 6, 477-480.
71. Agematsu, K., Kobata, T., Sugita, K., Hirose, T., Schlossman, S. F., Morimoto, C. (1995) Direct cellular communications between CD45RO and CD45RA T cell subsets via CD27/CD70. J. Immunol. 154, 3627-3635.
72. + T cells. J. Immunol. 154, 9-16.
73. Alzona, M., Jack, H. M., Fisher, R. I., Ellis, T. M. (1994) CD30 defines a subset of activated human T cells that produce IFN-gamma and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153, 2861-2867.
74. Romagnani, S., Del Prete, G., Maggi, E., Chilosi, M., Caligaris-Cappio, F., Pizzolo, G. (1995) CD30 and type 2 T helper (Th2) responses. J. Leukoc. Biol. 57, 726-730.
75. Gruss, H. J., Boiani, N., Williams, D. E., Armitage, R. J., Smith, C. A., Goodwin, R. G. (1994) Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83, 2045-2056.
76. Biswas, P., Smith, C. A., Goletti, D., Hardy, E. C., Jackson, R. W., Fauci, A. S. (1995) Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2, 587-596.
77. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J. P., van Kooten, C., Liu, Y. J., Rousset, F., Saeland, S. (1994) The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
78. Graf, D., Muller, S., Korthauer, U., van Kooten, C., Weise, C., Kroczek, R. A. (1995) A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation. Eur. J. Immunol. 25, 1749-1754.
79. Lane, P., Brocker, T., Hubele, S., Padovan, E., Lanzavecchia, A., McConnell, F. (1993) Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177, 1209-1213.
80. Fanslow, W. C., Srinivasan, S., Paxton, R., Gibson, M. G., Spriggs, M. K., Armitage, R. J. (1994) Structural characteristics of CD40 ligand that determine biological function. Semin. Immunol. 6, 267-278.
81. Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., Geha, R. S (1994) CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91, 12135-12139.
82. Renshaw, B. R., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., Maliszewski, C. R. (1994) Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180, 1889-1900.
83. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfeld, R. W., Kiener, P. A., Aruffo, A. (1995) Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182, 33-40.
84. Calderhead, D. M., Buhlmann, J. E., van den Eertwegh, A. J., Claassen, E., Noelle, R. J., Fell, H. P. (1993) Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J. Immunol. 151, 5261-5271.
85. Latza, U., Durkop, H., Schnittger, S., Ringeling, J., Eitelbach, F., Hummel, M., Fonatsch, C., Stein, H. (1994) The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24, 677-683.
86. Baum, P. R., Gayle, R. B., Ramsdell, F., Srinivasan, S., Sorensen, R. A., Watson, M. L., Seldin, M. F., Baker, E., Sutherland, G. R., Clifford, K. N., et al. (1994) Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13, 3992-4001.
87. Kwon, B. S., Kozak, C. A., Kim, K. K., Pickard, R. T. (1994) Genomic organization and chromosomal localization of the T-cell antigen 4-1BB. J Immunol 152, 2256-2262.
88. Pollok, K. E., Kim, Y. J., Zhou, Z., Hurtado, J., Kim, K. K., Pickard, R. T., Kwon, B. S. (1993) Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol. 150, 771-781.
89. Pollok, K. E., Kim, Y. J., Hurtado, J., Zhou, Z., Kim, K. K., Kwon, B. S. (1994) 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur. J. Immunol. 24, 367-374.
90. Schwarz, H., Valbracht, J., Tuckwell, J., von Kempis, J., Lotz, M. (1995) ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85, 1043-1052.
91. Callard, R. E., Armitage, R. J., Fanslow, W. C., Spriggs, M. K. (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol. Today 14, 559-564.